Integrated Investment Consultants’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,233
Closed -$110K 838
2018
Q1
$110K Buy
+1,233
New +$118K 0.04% 313
2017
Q3
$210K Buy
1,437
+68
+5% +$9.26K 0.09% 150
2017
Q2
$178K Hold
1,369
0.08% 170
2017
Q1
$170K Hold
1,369
0.08% 175
2016
Q4
$158K Hold
1,369
0.08% 182
2016
Q3
$138K Buy
1,369
+30
+2% +$3.25K 0.07% 198
2016
Q2
$132K Buy
1,339
+240
+22% +$24.8K 0.07% 204
2016
Q1
$117K Buy
+1,099
New +$113K 0.07% 199

Other funds holding CELG

Integrated Investment Consultants's CELG Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 1,233 shares — an estimated $110K sold.

Integrated Investment Consultants first reported a position in CELG in Q1 2016 and held it in 8 quarters. The position peaked at $210K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,233 Celgene Corp shares in Q2 2018, an estimated $110K.
  • Integrated Investment Consultants first reported a position in Celgene Corp in Q1 2016 and held it in 8 quarters.
  • Integrated Investment Consultants's Celgene Corp position peaked at $210K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.